The association says it is 'astonished' after the federal government disregarded the findings of a Senate inquiry, failed to consult, and used the last day of the parliamentary sitting year to table enabling legislation that will cut the value of the R&D Tax Incentive.
AusBiotech 'astonished' after R&D tax cut legislation tabled on final day
December 6, 2019 Latest News
Latest Video
New Stories
-
Most Australians want PBS medicine prices frozen or cut, poll finds
October 30, 2026 - - Latest News -
Canberra program shows young women where a future in health could take them
October 30, 2026 - - Latest News -
If only these patients needed a Spoodle, rather than a medicine
October 30, 2026 - - Latest News -
A hearing that provided more evidence of the need for meaningful change
October 29, 2026 - - Latest News -
Biotech sector warns R&D tax changes could drive clinical trials offshore
October 28, 2026 - - Latest News -
Rebates and net spend are the major PBS story of the past decade
October 28, 2026 - - Latest News -
Astellas bets up to US$1.34 billion on Melbourne startup's cancer candidate
October 28, 2026 - - Latest News
